STROCYTOMAS are the most common primary human brain tumors. The majority of astrocytomas are histopathologically malignant lesions associated with a poor prognosis. Patients harboring the most malignant form of astrocytoma, GBM, face a median survival time of only 12 months despite having undergone surgery, cranial radiation treatment, and intensive chemotherapy. Malignant astrocytomas rarely metastasize systemically; rather, death results from inexorable local tumor growth and brain invasion.
sion models do not take into consideration the unique representation of ECM macromolecules in the brain; and second, unequivocal identification of tagged and nonperturbed human astrocytoma cells within the selected model of brain tumor invasion has not been consistently achieved.
To overcome these difficulties, we have modified existing organotypical models of cultured rodent brain tissue to establish a reproducible and relevant model for human astrocytoma cell invasion. In addition, we have labeled human astrocytoma cells with GFP, which serves as a reporter molecule for monitoring astrocytoma cell invasion in our model. Finally, to determine whether this model is useful in measuring differential migratory rates among astrocytoma cells, we have cotransfected human astrocytoma cells with a cDNA for RHAMM 17, 18, 56, 57 as well as GFP. In this article we show that RHAMM-transfected human astrocytoma cells invade human brain tissue to a greater extent than control tumor cells, and that the degree of this invasiveness is both quantifiable and reproducible.
Materials and Methods

Astrocytoma Cell Lines, Culture Conditions, and Specimens of Tumor and Nonneoplastic Brain
The human malignant astrocytoma cell lines U87 and U343 were grown in monolayer cultures. These two cell lines were selected because of their differing basal motility rates in vitro. The U87 is a highly motile and invasive astrocytoma cell line both in vitro and in vivo, 34 whereas the U343 cell line is not. 49 The cell lines were routinely maintained in ␣-MEM supplemented with 10% FCS, 100 U/ ml penicillin, 100 g/ml streptomycin, and 0.25 g/ml amphotericin B. The astrocytoma cell lines were grown in a humidified environment containing 5% CO 2 at 37˚C.
Low-and high-grade human astrocytoma specimens (Grades II and IV according to the World Health Organization classification) were obtained during craniotomy. Specimens of human brain were also obtained during the course of routine craniotomies that were performed to treat arteriovenous malformation, trauma, or epilepsy in children and young adults aged 12 to 18 years. Permission to use these tissues was obtained from the Research Ethics Board of The Hospital for Sick Children. The brain tumor specimens were used in the immunohistochemical experiments described later in this paper. Nonneoplastic brain tissue was used in both immunohistochemical and brain slice experiments. Specimens obtained from surgical cases were either used immediately in fresh form or snap frozen and stored in liquid nitrogen for later use.
Astrocytoma Cell Line Transfections
Enhanced GFP vector was used to transfect U343 and U87 human astrocytoma cells and to label these cells with GFP. Approximately 1.6 ϫ 10 7 astrocytoma cells were trypsinized in 0.25% trypsin, pelleted, and washed in 5 ml of ice-cold sterile Ca ++ /Mg ++ -free PBS before they were repelleted and resuspended in sterile Ca ++ / Mg ++ -free PBS. Astrocytoma cells were added to 25 g of the aforementioned plasmids in a 0.45-cm electrode-gap electroporation cuvette and incubated on ice for 15 minutes. The specific electroporation voltage and capacitance values required to produce 50% cell death were ascertained and applied. 52 For efficient transfection, the U87 and U343 cells required 350 V and 250 mF, and the U343 cells required 300 V and 500 mF. Following electroporation, the cells were incubated on ice for 30 minutes before cells from a single-cell suspension were plated onto 100-mm 2 tissue culture dishes. Forty-eight hours after electroporation, the medium was replaced with ␣-MEM containing 0.6 mg/ml G41. Cell colony formation was observed over time by using phase microscopy. Expression of GFP was detected by direct visualization, Western blot, and FACS analysis. For Western blot analysis, a GFP polyclonal antibody (diluted 1:2000) was used. The FACS analysis was performed on live cells. When individual fluorescent colonies had accumulated 50 to 100 cells (approximately 2 weeks postelectroporation), they were lifted separately from the tissue culture plates by using a P-200 micropipette tip under microscopic guidance. These colonies were then expanded as separate clones of cells in G418-containing media in new tissue culture dishes.
To determine the effects of RHAMM transfection on astrocytoma migration through the brain slice model, we obtained a cDNA probe for the entire coding sequence of the RHAMMv4. 18 The RHAMM cDNA was ligated at cohesive ends into pEGFP-C1 in both sense and antisense orientations. Confirmation of sense and antisense orientations of the RHAMM cDNA was confirmed by restriction digest analysis. Transfections were performed as described earlier. Controls for the effects of RHAMM modulation in these cell clones were the transfections of the astrocytoma cell lines with the pEGFP vector by itself.
Proliferation of Transfected Astrocytoma Cell Clones and Controls
Parental U87 and U343 astrocytoma cell lines, RHAMM-GFP transfectants, and control cells were seeded at 5 ϫ 10 5 cells in 60-mm 2 tissue culture dishes. Cells were harvested and counted daily for 10 days. Growth curves were generated for all astrocytoma clones. The doubling time for each clone was calculated from the slope of the logarithmic portion of the growth curve, as described previously. 48 
Immunohistochemical Localization of RHAMM in Astrocytomas
Paraffin-embedded sections of human brain and low-and highgrade astrocytomas were deparaffinized, bleached in hydrogen peroxide and methanol, and washed in distilled water. The sections were blocked with 0.5% bovine serum albumin and 0.5% normal goat serum in PBS and incubated with a rabbit polyclonal antibody specific to RHAMM (antibody AP-HV42.1, 0.64 mg/ml, diluted 1:100). 18 Peroxidase-labeled secondary antibodies (goat/anti-rabbit/ horseradish peroxidase, 1:200 dilution) were then used. The samples were treated with 3.3Јdiaminobenzidine and 30% hydrogen peroxide. Counterstaining was performed by using the Harris-hematoxylin technique. As a negative control, secondary antibodies were used without addition of primary antibodies.
Brain Slice Model
To establish this model, modifications were made to existing neural organotypical cultures in a manner previously described. 26, 54, 55 For the purposes of this study, only frontal and temporal lobe specimens were used and examined. Specimens of human brain were cut by using sterile scalpel blades in a sterile environment. Gray matter was separated from white matter. Specimens of white matter were cut into 1-mm-thick 8 ϫ 8-mm 2 slices by using a brain slicing apparatus. The brain slices were placed in the upper chambers of 24-mm Transwell culture dishes (0.4-mm pore size) and incubated in medium 55 containing ␣-MEM and 10% FCS supplemented with glutamine, insulin/transferrin/splenium-A (ϫ 100), glucose, and 20 nM progesterone (Fig. 1) . After allowing the brain slices to equilibrate in medium for 24 hours, a 2-mm hole was made in the center of the brain slice by using a micropipette tip. Following this, 5 ϫ 10 5 RHAMM-GFP-transfected astrocytoma cells or control cells were placed in the central hole of the brain slice and incubated for different lengths of time. The culture medium was carefully changed every 3 days. After 7 days in culture, the brain slices were fixed in a 4% paraformaldehyde solution 12, 13, 60 (0.1 M phosphate buffer, pH 7.2) and placed on specially adapted microscopy slides. Mounting medium was added to maintain the 3D structure of the brain slices. The samples were then imaged using scanning confocal laser microscopy. A maximum of 250 1-m-thick optical sections were collected using a GFP barrier filter. The sections were then rendered into a pseudo-3D perspective by using a computer program. The distance from the point of implantation (the fissure in which the cells were implanted) to the point at which the individual GFP-labeled cells migrated was then calculated. Each cell's migra-tion was placed in a distance category by measuring the distance that the cell had traversed and then rounding off the distance value to the closest distance category. The cell density (cells/mm 3 ) for each category and each cell type was expressed as a mean and standard deviation. Significance was then determined using Student's t-test. 12, 13, 60 In separate experiments, we determined the rate of migration of RHAMM-transfected GFP-tagged U87 astrocytoma cells through brain slice preparations derived from temporal and frontal lobe specimens at 3, 5, and 7 days postimplantation.
Preparation of Brain Slice Specimens for TEM
To study the ultrastructural features of astrocytoma invasion into the brain slices and to assess their cytoarchitectural integrity over time, slices of brain that had been cultured for varying time periods were fixed for 4 hours, washed with buffer, and postfixed using phosphate-buffered osmium tetroxide. Samples were dehydrated by treating them with a series of ascending concentrations of ethanol. The samples were embedded in Epon-Araldite by using propylene oxide. Ultrathin sections exhibiting a pale-gold interference color (indicating that there was sufficient brain tissue for TEM analysis) were mounted on grids and stained with uranyl acetate and lead citrate. These specimens were then examined and photographed using a transmission electron microscope. The cDNA probe for the coding sequence of the RHAMMv4 and the AP-HV42.1 antibody were generous gifts from Dr. Eva Turley 18 (The Hospital for Sick Children).
Sources of Supplies and Equipment
Results
Isolation of Stable GFP-Transfected Astrocytoma Clones
Following transfections with RHAMM-GFP expression vectors, 60 clones were examined for expression of the RHAMM-GFP fusion protein. Ten clones of the U87 cell line and eight of the U343 cell line were found to express variable levels of RHAMM-GFP. Of these, one cell clone for each astrocytoma cell line that demonstrated stable and high-level expression of GFP according to the results of the FACS (Figs. 2) and Western blot (Fig. 3) analyses were selected for all additional experiments. Transfection of the human astrocytoma cell lines with RHAMM-GFP did not affect the proliferation of these clones, as determined by growth-curve analysis and calculation of doubling times (Fig. 4) .
Expression of RHAMM by Human Astrocytoma Cells
Ten different specimens each of nonneoplastic brain, low-grade astrocytoma, and GBM were examined for RHAMM expression by using immunohistochemical analysis. Weak expression of RHAMM was found in nonneoplastic brain tissue and low-grade astrocytomas. In contrast, RHAMM was more strongly expressed in higher-grade astrocytic neoplasms such as GBM (Fig. 5) .
Analysis of GFP-Labeled Astrocytoma Invasion of Brain Slices
Hematoxylin and eosin staining of organotypical cultures of human brain slices demonstrated histological integrity 1 week after placement in culture. Results of previous studies performed using unlabeled astrocytoma cells demonstrated the ability of these cells to penetrate the brain slices; 26 however, the unequivocal identification of the solitary invading astrocytoma cell was not possible. Using GFP-transfected astrocytoma cells, we were able to show that astrocytoma invasiveness is readily detected by confocal laser microscopy (Fig. 6) . The RHAMMtransfected astrocytoma cells exhibited a spindle-shaped, bipolar structure compared with antisense RHAMMtransfected cells within the brain slice. Several RHAMMtransfected astrocytoma cells acquired long cell processes, which reached forward into the parenchyma of the brain slice. Antisense RHAMM-transfected U87 astrocytoma cells, in particular, displayed a round, globular phenotype within the brain slice (Fig. 6D) .
The distance that the GFP-labeled astrocytoma cells migrated from the site of implantation in the fissure into the depths of the brain slice was measured. The control U87 astrocytoma cells migrated farther than the U343 astrocytoma cells (Fig. 7) . The RHAMM-transfected U87 and U343 astrocytoma cells migrated farther into the brain slices than the controls. In contrast, antisense RHAMMtransfected astrocytoma cells displayed poor migration into the brain slice and were found predominantly within 1 mm of the site of implantation.
At 3, 5, and 7 days, we observed that the RHAMMtransfected U87 astrocytoma cells had penetrated the brain slice preparations to mean distances (Ϯ standard deviations) of 0.5 Ϯ 0.2 mm, 1.8 Ϯ 0.4 mm, and 3 Ϯ 0.5 mm, respectively. There was no significant difference in the rate of migration of RHAMM-transfected U87 astrocytoma cells in specimens derived from either temporal or frontal lobe locations (data not shown).
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Brain Slice Specimens Shown to Have Cytoarchitectural Preservation by TEM
Examination of brain slice specimens containing implanted astrocytoma cells incubated for 3, 5, 7, and 14 days revealed astrocytoma cells with rich filamentous structures within intact neuropil containing readily identifiable myelinated axons (Fig. 8) . However, at 30 days postimplantation the neuropil was found to be degenerating, and necrosis of astrocytes and neurons was observed (data not shown).
Discussion
We have shown that the invasive potential of GFPlabeled human astrocytoma cells can be assessed by using organotypical brain slices derived from nonneoplastic cerebral tissue as a barrier to astrocytoma invasion. The migratory behavior of infiltrating human astrocytoma cells was readily tracked by using confocal laser microscopy. Astrocytoma cells transfected with a RHAMMv4 cDNA were stimulated to migrate faster than non-RHAMM-transfected astrocytoma cells. Interestingly, antisense RHAMM-transfected astrocytoma cells showed little if any migratory potential when placed within the implantation site of the brain slice model. Together, these results suggest that our model may have utility as an in vitro system with which we can further our understanding of the process of astrocytoma invasion.
Several in vitro invasion assays have been developed that present various ECM macromolecules as barriers to tumor invasion, including natural tissues such as amnion and eye lens, or ECM gels such as type I collagen gels or the gelled basement membrane extract Matrigel. 19, 24, 29, 32, 38, 45 The Matrigel invasion assay has been the most widely used because it is quick, reliable, easy to quantitate, and available commercially. 2, 6, 25 There has been a consistent correlation between the malignancy of a cell and its ability to infiltrate through Matrigel. 2, 6, 25, 38 Matrigel is a soluble basement membrane extract of the Engelbreth-HolmSwarm tumor, which gels to form a reconstituted basement membrane, as shown by its composition, structure, and physical properties. 28 The major components of Matrigel are laminin, collagen IV, entactin, and heparan sulfate proteoglycan. 58 Although some of these ECM macromolecules are found within the defined basal laminae at the glial limitans externa or around cerebral blood vessels in the central nervous system, invasive astrocytoma cells do not frequently breach these structures. Instead, astrocytoma cells are characterized by their diffuse infiltration of brain parenchyma, especially within and along white matter tracts. As such, the Matrigel invasion assay does not provide an adequate modeling of the ECM normally encountered by infiltrating astrocytoma cells.
The limited applicability of Matrigel and other conventional membrane-based systems (in which single tumor cells invade a nonviable matrix) to the process of brain tumor invasion has spawned the development of a tumor cell-invasion model in which the interactions of both malignant and normal cells can be studied within a 3D framework. In this model, tumor cell fragments are placed side by side with normal tissue in a confrontational assay system. 3, 14, 15 To make this model relevant to brain tumor invasion, Bjerkvig and colleagues 7, 8, 16, 41, 42 used fetal rat brain cell aggregates as targets for brain tumor spheroids obtained from permanent glioma cell lines and primary human brain tumor biopsy specimens. In their model, brain tumor cell invasion was assessed after 72 to 120 hours of coculture. These investigators reported that spheroids obtained from biopsy specimens of primary intracranial tumors with different histological characteristics and malignancy grades demonstrated the same growth and invasiveness that these tumors displayed in vivo. 16, 41, 42 Although such confrontation systems are advantageous in the study of tumor invasion, widespread acceptance has been limited for two main reasons. First, the fetal rat brain, which is used as a target for human brain tumor cells, has a distinctly different ECM than the adult rat brain or, for that matter, the human brain. 46 Second, it has proven difficult to quantify the degree to which brain tumor cells invade normal brain. Some of these difficulties have been overcome by labeling human glioma cells with fluorescent vital dyes before placing them in the coculture confrontation system. 33 Because the Matrigel and coculture-confrontation in vitro systems do not provide the normal cytoarchitectural pattern of differentiated neural tissue or the biochemical and electrophysiological functions of normal neurons, we sought to use brain organotypical cultures to study human astrocytoma invasion. 26, 37 Brain organotypical cultures have long played an important role in elucidating mechanisms related to fiber outgrowth, myelin formation, and
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Use of GFP to track astrocytoma invasiveness in a brain slice model the development of synaptic networks. 22, 23 The characteristic cytoarchitecture and distinct organization of brain tissue can be maintained in this system for several weeks to months. 22, 23, 55 Ohnishi, et al., 37 used rat brain slices obtained from the hippocampus or cortical regions of 2-dayold rats and maintained the brain slices in culture at the interface between air and the culture medium. These cultures could be maintained with adequate tissue preservation for extended periods of observation, frequently longer than 1 month. The C6 rat glioma spheroids were labeled with a PKH2 fluorescent marker before placement on the brain slices. In addition, these authors used L1-expressing fibroblasts in coculture with the brain slice preparations to stimulate C6 glioma spheroid migration. 37 In fact, stimulation with L1, a neural cell adhesion molecule, was absolutely required for marked C6 glioma migration. 37 In contrast to the model described by Ohnishi, et al., we used human tissue derived from surgical specimens obtained in patients undergoing temporal lobectomies for seizure disorders. To simulate the clinical situation in which astrocytoma cells disperse most frequently along white matter tracts, we used white matter freshly dissected from these specimens as the barrier to human astrocytoma cell infiltration. Confocal laser microscopy was then used to track and identify astrocytoma cells within the brain tissue.
However, single-cell infiltration and micrometastasis have often been difficult to study in experimental tumor models and in histopathological preparations because of a lack of suitable and sensitive markers that can discriminate individual tumor cells from normal cell populations. Recently, vital dyes such as fast blue, FluoroGold, 1,1Ј-dioctadecyl-3,3,3Ј,3Ј-tetramethylindocarbocyanine perchlorate, and 3,3Ј-diaoctadecyloxacarbocyanine perchlorate have been developed to track neural cell populations in complex tissues. 4, 20, 33 Even though several of these vital dyes are regarded as nontoxic, it remains unclear how and to what extent these compounds affect cellular behavior. To overcome the deficiencies of vital dye markers, several reporter genes have been used to study the migration of human astrocytomas in vitro and in vivo. 4, 10, 11, 20, 30, 33, 39, 40 The bacterial Escherichia coli lacZ gene has been the most common reporter gene used in numerous transfec- FIG. 7 . Bar graphs depicting the extent of invasion of brain slices by human astrocytoma cells, as shown using quantitative morphometric analysis at 7 days postimplantation. The extent of migration by GFP-expressing astrocytoma cells was measured from the implantation site (fissure) into the substance of the brain slice in millimeters. The U343 astrocytoma cells migrated less readily into the brain slice than the U87 cells (mean 1.5 mm compared with 2.5 mm, p Ͻ 0.05). The pEGFP antisense RHAMM-transfected cells were virtually prevented from entering the brain slices. The RHAMMtransfected U87 and U343 astrocytoma cells were capable of traveling farther within the brain slice than the astrocytoma cell lines transfected with GFP alone. tion studies and gene therapy experiments. 44 The LacZ gene can be stably transfected into most tumor cell lines by using both liposomes and viral vectors as vehicles for gene delivery. 31 Problems with the use of bacterium-derived lacZ as a reporter gene arise from the fact that intracellular ␤-gal has antigenic properties when inserted into nonimmunogenic glioma cell lines, with the result that transfer of this gene into a highly tumorigenic cell line may reduce the cell's tumorigenicity. 1, 30 Furthermore, analysis of lacZ-transfected cells in tissues requires the sacrifice either of the animal or of a portion of the tissue, because fixation at a neutral pH is required to view expression of the blue product.
Another marker for gene expression that has become popular in recent times is GFP. This protein is naturally produced by the bioluminescent jellyfish Aequorea victoria in which calcium binds to the phosphoprotein aqueorin. The GFP is a 238-amino acid peptide that absorbs blue light and emits green light without the need for additional cofactors or substrates. 9 This protein has been used to monitor gene expression and protein localization in living organisms, as well as to infect neurons in frog brains 59 and to visualize cancer invasion and metastasis. 12, 13 In our study, transfection of human astrocytoma cells with a GFP expression vector enabled us to establish a heritable, stable volume marker for the unequivocal identification of invasive astrocytoma cells in our brain slice model. Both U87 and U343 astrocytoma cell lines penetrated the brain slice to different degrees. Following 5 days of culture, GFP-positive U87 astrocytoma cells were found at distances of 2.5 mm from the primary implantation site, whereas U343 astrocytoma cells were limited to distances of 1.5 mm. This difference in invasiveness between these two cell lines correlates well with their known tumorigenicity: U87 astrocytoma cells are highly tumorigenic in athymic mice, whereas U343 cells are not. Interestingly, migratory GFP-positive human astrocytoma cells were capable of changing their structure from that of round flat cells (as seen in vitro) to that of bipolar spindle-shaped cells within the brain slices. The GFP transfection of astrocytoma cells did not alter astrocytoma proliferation or growth rates.
To determine whether the migration of human astrocytoma cells through the brain slices could be stimulated, we transfected the cell lines with an RHAMMv4 cDNA. A well-described hyaluronic acid receptor, RHAMM has been shown to be critical for cell locomotion. 56 We have shown by immunohistochemical analysis that RHAMM is minimally expressed by astrocytes in normal human brain. However, with increasing astrocytic anaplasia, RHAMM expression increases. Following RHAMMv4 transfection, we found that U343 and U87 human astrocytoma cells were capable of penetrating brain slices to a significantly greater degree than control cells, as measured by the detection of GFP-positive cells by using confocal laser microscopy. Interestingly, invasion was virtually abolished in our brain slice system by the use of antisense RHAMM transfections of the astrocytoma cell lines. These data indicate not only that RHAMM may be an important mediator of motility in the 3D context of our brain-slice model, but also that differences in degrees of invasion in a given cell line can be measured accurately and reproducibly by using our model.
Although our brain slice culture system has several limitations, such as abrogation of vascular supply to the tissue, finite lifespan of the tissue in vitro, and lack of directed immune responsiveness to the implanted tumor cells, we have observed that the cytoarchitecture of the brain tissue remains viable and intact for 14 days without exhibiting obvious histopathological signs of necrosis. As such, our human brain slice model has several distinct advantages over the conventional basement membranebased assays and the confrontational assay system for the study of human astrocytoma invasion. Using the confocal laser microscopic images, we were able to observe invasion patterns in different axial planes and, finally, to cre-
Use of GFP to track astrocytoma invasiveness in a brain slice model ate a 3D image demonstrating the relationship between tumor cells and normal brain. Tumor spread within the brain slice was quite obvious within the first several days of incubation.
Of course, the ideal model to study brain invasion would be homologous, immunocompetent, and in vivo. The superiority of animal models over purely in vitro experimentation consists in the fact that in vivo studies of chemosensitivity and anticancer drug pharmacology can take advantage of the growth of glioma cells as a 3D tumor within a living organism. However, human astrocytomas that are xenotransplanted into the brain of the athymic mouse grow predominantly by expansion rather than diffuse filtration, due to their high proliferative rates. 43, 53 Spontaneous brain tumors in animals may provide the cleanest, most natural model with which to work, but these tumors occur far too infrequently to allow consistent study, and the problem of identifying solitary infiltrating tumor cells remains.
Recently, Farina and associates 21 described the tracking of GFP-labeled rat mammary adenocarcinoma cells orthotopically implanted into the mammary fat pad of live, immunocompetent, and homologous female rats. Movement of metastatic tumor cells in live rats was depicted by means of intravital imaging of the primary tumor in situ performed with the aid of a scanning confocal laser microscope. These investigators showed that only a small fraction of primary tumor cells in a tumor mass are actively motile; tumor cells become actively motile as they disseminate from the primary site. Although this model may be construed as the ultimate design for studying tumorcell motility and invasion, it is technically demanding and labor intensive, requiring anesthetization of the animal, surgical exposure of an accessible tumor, and intravital imaging over extended time periods. As such, its applicability to brain-tumor invasion, in which the tumors are not readily accessible and amenable to intravital imaging, will be limited.
Conclusions
We have described an organotypical human brain slice model to be used for studying human astrocytoma invasion. Using this model, GFP-labeled human astrocytoma cells can be tracked reliably and reproducibly. In this study, RHAMMv4-stimulated human astrocytoma cells migrated at faster rates through the brain slice than control tumor cells. We believe this model has merit compared with existing models as a means of studying patterns of human astrocytoma invasion. Studies are underway in which the unique features of this model are being implemented to determine whether inhibitors of invasion can be developed to help in the treatment of these surgically and medically recalcitrant tumors.
